Camelot Portfolios’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-600
| Closed | -$63.9K | – | 418 |
|
|
2024
Q2 | $63.9K | Buy |
+600
| New | +$63.9K | 0.04% | 281 |
|
|
2019
Q1 | – | Sell |
-11,230
| Closed | -$863K | – | 251 |
|
|
2018
Q4 | $863K | Buy |
11,230
+137
| +1% | +$10.5K | 0.4% | 75 |
|
|
2018
Q3 | $856K | Sell |
11,093
-121
| -1% | -$9.34K | 0.39% | 70 |
|
|
2018
Q2 | $759K | Sell |
11,214
-941
| -8% | -$63.7K | 0.32% | 85 |
|
|
2018
Q1 | $881K | Sell |
12,155
-284
| -2% | -$20.6K | 0.41% | 71 |
|
|
2017
Q4 | $936K | Buy |
12,439
+17
| +0.1% | +$1.28K | 0.44% | 66 |
|
|
2017
Q3 | $956K | Buy |
12,422
+303
| +3% | +$23.3K | 0.46% | 63 |
|
|
2017
Q2 | $906K | Sell |
12,119
-630
| -5% | -$47.1K | 0.45% | 58 |
|
|
2017
Q1 | $848K | Buy |
+12,749
| New | +$848K | 0.41% | 67 |
|
|
2015
Q1 | – | Sell |
-6,917
| Closed | -$574K | – | 178 |
|
|
2014
Q4 | $574K | Buy |
6,917
+65
| +0.9% | +$5.39K | 0.33% | 88 |
|
|
2014
Q3 | $578K | Buy |
6,852
+341
| +5% | +$28.8K | 0.34% | 87 |
|
|
2014
Q2 | $528K | Sell |
6,511
-3,120
| -32% | -$253K | 0.34% | 86 |
|
|
2014
Q1 | $734K | Sell |
9,631
-12,587
| -57% | -$959K | 0.5% | 60 |
|
|
2013
Q4 | $1.6M | Buy |
22,218
+1,403
| +7% | +$101K | 1.03% | 22 |
|
|
2013
Q3 | $1.43M | Buy |
20,815
+729
| +4% | +$50.1K | 1.05% | 22 |
|
|
2013
Q2 | $1.27M | Buy |
+20,086
| New | +$1.27M | 0.97% | 24 |
|